


Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
+2.96%
+1.05%
+1.52%
+1.40%
+7.61%
PFE
Pfizer
$25.74
Strengths

Earnings are forecast to grow

Trading below its fair value

Upgraded on attractively valued

Investors confidence is positive
PFE Price Performance
$24.65 (+4.42%)
$24.54 (+4.89%)
$25.56 (+0.70%)
$25.3 (+1.74%)
PFE has Low risk level based on volatility, sector strength, volume, investor confidence, and outlook.
Click here to check what is your level of risk
Risks Indicators

Investors losing confidence

PFE overall standing based on key factors, offering insights into analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Above analyst estimates

Earnings decline YoY

Reported a strong earnings
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum

Has been gaining momentum
Activity
Activity

Investors confidence is positive
Future
Future

Earnings are forecast to grow

Trading below its fair value

Outperform the market
![]()
PFE Analysts opinion is positive and also has improved from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential
PFE Street Sentiment is extremely bullish and have positive views on the near-term outlook
Average key support and resistance price levels
Login to displayNVS
130.40
-0.03%
SNY
49.88
-0.30%
MRK
104.83
+0.19%
AZN
92.73
-0.63%
ABBV
227.70
+0.02%
What is PFE current stock price?
What are PFE stock strengths?
What is PFE Risk Level?
What is PFE market cap and volume?
What is PFE current Stock IQ?
Should I buy PFE stock right now?
Is PFE a Strong Buy right now?
What does a 'Strong Buy' rating mean for PFE?
What does a 'Strong Sell' rating mean for PFE?
What factors influence PFE's Stock IQ?
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
+2.96%
+1.05%
+1.52%
+1.40%
+7.61%
PFE
Pfizer
Current Price
$25.74
Stock Insights
Strengths

Earnings are forecast to grow

Trading below its fair value

Upgraded on attractively valued

Investors confidence is positive
Linked to PFE
NVS
130.40
-0.03%
SNY
49.88
-0.30%
MRK
104.83
+0.19%
AZN
92.73
-0.63%
ABBV
227.70
+0.02%

PFE Price Performance
$24.65 (+4.42%)
$24.54 (+4.89%)
$25.56 (+0.70%)
$25.3 (+1.74%)
PFE Analysts Opinion
PFE Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Above analyst estimates

Earnings decline YoY

Reported a strong earnings
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum

Has been gaining momentum
Activity
Activity

Investors confidence is positive
Future
Future

Earnings are forecast to grow

Trading below its fair value

Outperform the market
![]()
PFE Analysts opinion is positive and also has improved from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential
PFE Street Sentiment is extremely bullish and have positive views on the near-term outlook
PFE has Low risk level based on volatility, sector strength, volume, investor confidence, and outlook.
Click here to check what is your level of risk
Risks Indicators

Investors losing confidence

Average key support and resistance price levels
PFE Stock IQ
PFE Latest Analysis
Guggenheim Lifts PT on Pfizer Inc. (PFE) to $35 From $33 Keeps a Buy Rating. Pfizer Inc. (NYSE:PFE) is one of the best low volatility large cap stocks to invest in. On November 24 Guggenheim lifted the price target on Pfizer Inc. (NYSE:PFE) to $35 from $33 while keeping a Buy rating on the stock. The firm told investors that Pfizer Inc.s (NYSE:PFE) acquisition of Metsera Inc. marks a a [….]
Fri Nov 28, 2025
Valneva Posts Positive Lyme Vaccine Booster Results — Pfizer Targeting 2026 Regulatory Filings. ) shared final immunogenicity and safety data on Wednesday from the Phase 2 study VLA15-221 of the Lyme disease .Lyme disease is a bacterial infection transmitted to humans by infected ticks often presenting with an early “.’.s-eye”. rash and flu-like symptoms such as fever headache and fatigue.The results showed a strong anamnestic immune response and a favorable safety profile six mon
Wed Nov 26, 2025
Is This the Best Value Stock to Buy While Markets Are Volatile?. Key PointsPfizer possesses several qualities that make it attractive when market volatility is high.
Tue Nov 25, 2025
Guggenheim Maintains Pfizer (PFE) Buy Recommendation. Fintel reports that on November 24 2025 Guggenheim maintained coverage of Pfizer (NYSE:PFE) with a Buy recommendation. Analyst Price Forecast Suggests 17.56% Upside
Tue Nov 25, 2025
Why Are Shares of Pfizer Up Today?. Shares of ) are trading higher after a study found that the company’.s new mRNA flu vaccine outperforms traditional shots against predominant strains. published in the New England Journal of Medicine said that flu vaccine outperformed the standard flu shot in ...
Fri Nov 21, 2025
PFEs New & Acquired Drugs Drive Non-COVID Comeback as LOE Test Looms. Pfizers new and acquired drugs lift non-COVID revenue with recent launches and Seagen products driving momentum into 2026 despite looming LOEs.
Fri Nov 21, 2025
Pfizer: Is This Pharma Giant Finally A Bargain.
Wed Nov 19, 2025
Nona Biosciences and Pfizer Announce Strategic Research Collaboration to Accelerate Antibody Discovery. Agreement includes license to Nona'.s fully human HCAb platform for preclinical antibody discovery®. (Idea to IND) today announced a non-exclusive license agreement with Pfizer designed to accelerate preclinical antibody discovery across a range of potential disease indications. ...
Wed Nov 19, 2025
Pfizer Inc. (PFE) Presents at Jefferies London Healthcare Conference 2025 Transcript.
Wed Nov 19, 2025
Pfizer reportedly seeking $5B bond sale for Metsera acquisition.
Tue Nov 18, 2025
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.